SCHEMBL5887487

SCHEMBL5887487

COc1ccc(C2=C(c3ccccc3Cl)C=CC[CH]2)c2ccccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.37
EP300 Q09472 1/20 0.36
KAT8 Q9H7Z6 1/20 0.36
IMPDH2 P12268 1/20 0.35
IMPDH1 P20839 1/20 0.35
MAPT P10636 3/20 0.35
KMT2A Q03164 3/20 0.34
ALDH1A1 P00352 3/20 0.34
CYP1A1 P04798 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP1B1 Q16678 2/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6047631 0.82 IDO1 (0.40) IDO1EP300KAT8IMPDH2IMPDH1
SCHEMBL5887354 0.80 SMN1; SMN2 (0.38) MAPTKMT2AALDH1A1MEN1NPC1
SCHEMBL5887681 0.78 IDO1 (0.37) IDO1EP300KAT8IMPDH2IMPDH1
SCHEMBL6047658 0.77 NPC1 (0.41) MAPTKMT2AALDH1A1CYP1A2MEN1
SCHEMBL6047637 0.70 IDO1 (0.37) IDO1EP300KAT8IMPDH2IMPDH1
SCHEMBL12019937 0.68 IDO1 (0.59) IDO1EP300KAT8IMPDH2IMPDH1
SCHEMBL12019868 0.68 IDO1 (0.59) IDO1EP300KAT8IMPDH2IMPDH1
SCHEMBL12019841 0.68 IDO1 (0.64) IDO1EP300KAT8IMPDH2IMPDH1
SCHEMBL7753164 0.68 IDO1 (0.64) IDO1EP300KAT8IMPDH2IMPDH1
SCHEMBL12019777 0.68 IDO1 (0.64) IDO1EP300KAT8IMPDH2IMPDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 US claimed
JP-2006501194-A 2006-01-12 JP claimed
EP-1525190-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-04-27 EP claimed
WO-2004007463-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-01-22 WO claimed